Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel pharmacological effect described for tyrosine kinase inhibitor STI-571

July 23, 2001

Naturally occurring estrogen-like agonist discovered by Nippon Kayaku

July 20, 2001

MorphoSys reaches milestone in antibody collaboration with GPC Biotech

July 20, 2001

MetaPhore's M-40403 successfully completes phase I evaluation

July 20, 2001

Hybrid compounds designed to have enhanced minor groove binding and cytotoxic activity

July 20, 2001

Decitabine holds potential for chemotherapy of resistant ovarian and colon cancer

July 20, 2001

Bristol-Myers Squibb and Exelixis focus on tumor suppressor genes

July 19, 2001

Promising preclinical antiangiogenic, antitumor activity described for PKCbeta inhibitor

July 19, 2001

Antibody to high-molecular-weight kininogen effectively inhibits angiogenesis in tumor models

July 19, 2001

BTG commences phase I clinical trial of new anticancer agent

July 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...